Nova Molecular Technologies, Inc.
https://novamolecular.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nova Molecular Technologies, Inc.
Neurotrophic Bioscience Inc.
Despite setbacks by neuroscience companies Cephalon Inc. and Regeneron Pharmaceuticals Inc., the hope that neurotrophic factors will provide relief for millions of sufferers of neurodegenerative diseases, by slowing the progression of the disease, is alive and kicking. Neurotrophic Biosciences hopes to succeed where others have not by taking an approach that will apply combinations of highly specific neurotrophic factors, many of them newly discovered, to the treatment of neurodegenerative diseases.
Nova Molecular Inc.
Nova Molecular hopes to match the right Alzheimer's patients with the right drugs using pharmacogenetics.
Inventing the Pharmacogenomics Business
Applying genomics technologies to drugs on market or in clinical development holds great promise. Drug companies can revive tired products by finding new customers, redefine the market for approved compounds, and design more effective medications. But the real commercial possibilities have yet to be tested.
Company Information
- Industry
- Miscellaneous
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice